One-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

BACKGROUND: This prospective, open-label, non-comparative, multicentre, long-term phase IV study is examining the efficacy and safety of somatropin [recombinant human growth hormone (rhGH)] in short children born small for gestational age (SGA) and its impact on the incidence of diabetes. This repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Hans-Peter, Birkholz-Walerzak, Dorota, Szalecki, Mieczyslaw, Walczak, Mieczyslaw, Galesanu, Corina, Metreveli, David, Khan-Boluki, Jasmin, Schuck, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254863/
https://www.ncbi.nlm.nih.gov/pubmed/24676989
http://dx.doi.org/10.1007/s13554-014-0014-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254863/
https://www.ncbi.nlm.nih.gov/pubmed/24676989
http://dx.doi.org/10.1007/s13554-014-0014-4

Ejemplares similares